Skip to content

Deaths in older children, teenagers with HIV set to grow in southern Africa

GS-9350 boosts atazanavir just as well as ritonavir

Tobacco, marijuana and alcohol may lower levels of some anti-HIV drugs

Dual maintenance therapy with atazanavir plus raltegravir sustains viral suppression

Once-daily Kaletra approved in the European Union

Boosted protease inhibitor regimens with 3TC work despite M184V resistance

Maturation inhibitor bevirimat is well tolerated and effective in predicted responders

Mental health and HIV: a clinical review

Mental health and HIV: a clinical review

GSK's second integrase inhibitor looks potent and well-tolerated in early study